# VITAMI EXPRESS — Execution Progress

Last recorded update: 2026-11-13

## Current stage
**Stage 1 — Scientific knowledge consolidation: 78% (working estimate).**

## Completed
- Central source registry expanded to 74 records.
- All 87 draft rules mapped to source IDs; all 31 safety gates mapped to source IDs.
- All source IDs used by the rule and safety-gate crosswalks reconcile to registered sources.
- Eight previously flagged library ingredients now have specific sources linked: MCT oil, inositol, NAC, alpha-lipoic acid, astaxanthin, lycopene, beta-carotene and spirulina.
- Eight preliminary evidence claims and eight preliminary scientific-review records created for those ingredients.
- 17 claim-to-source attribution records created with organization/source names, original links, provenance scope, no-endorsement policy and logo-permission safeguards.
- Library QA report updated: the eight ingredients remain under review and are not cleared for BASIC recommendations.
- Created a structured review queue for all 31 safety gates, preserving current overrides and requiring claim-level appraisal before any approval.
- Added a read-only Python integrity audit script and GitHub Actions workflow; first automated run succeeded with 0 errors and 0 warnings (74 sources, 87 rule mappings, 31 safety gates, 12 claims, 8 review records and 17 attributions).
- Stored the dated audit results and commit references in the repository.
- Extended source-registry integrity checks to require organization, document title, source class, review status, logo-use policy and valid original URLs (except explicit pending placeholders); second CI run also passed with 0 errors and 0 warnings.
- Four earlier draft claims and three draft rule justifications remain in place.
- Added 31 preliminary safety evidence records, one for each safety gate, and linked each record back into the gate crosswalk and structured review queue.
- Created a 39-entry source-attribution manifest for the 31 safety gates, including organization, exact document title, original URL, claim status and explicit logo-permission restrictions.
- Added three substantive, source-linked safety claims and targeted review records for vitamin B6 neurotoxicity (EFSA 2023 vs U.S. FNB UL distinction), preformed vitamin A in pregnancy, and psyllium swallowing/obstruction risk under 21 CFR §201.319.
- Added three corresponding draft rule justifications; all remain inactive pending full scientific, professional and jurisdictional review.
- Extended the automated integrity audit to require every safety gate to reference an existing preliminary claim and to prevent placeholder safety claims from being approved for display or activation.
- Source metadata, attribution, evidence-claim, scientific-review and rule-justification schemas are present.
- Source policy requires direct original links, identification of what each source supports, dates where available, and no implied endorsement.
- Existing repository coverage documented: 100 library entries, 40 deep-record files, 87 draft rules, 31 safety gates, 13 production candidates and 7 BASIC integration-ready scenarios.

## Remaining in Stage 1
- Complete full-text extraction and critical appraisal for all eight newly sourced ingredients.
- Apply risk-of-bias tools (RoB 2, AMSTAR 2 as appropriate) and assess certainty using GRADE where suitable.
- Convert source-only mappings into substantive, appraisable claim-level mappings across all 87 rules and 31 safety gates; the 31 current safety records are preliminary placeholders, not clinical validation.
- Extend automated checks to cover deeper schema validation, source metadata quality and user-facing attribution requirements.
- Reconcile deep-record directory and index counts.
- Complete ingredient-by-ingredient safety review and source currency checks.
- Expand the app-facing attribution layer and test display behavior, including permitted logos only.

## Guardrails
- Source registration and repository counts are not clinical validation.
- Preliminary claims and reviews are not approved for display or recommendation activation.
- The eight reviewed library entries remain excluded from BASIC recommendations until full review and professional approval.
- Draft rules remain inactive until scientific, safety and professional review.
- Logos are not displayed until usage permissions and brand guidelines are checked.
- Do not modify production or imply a public launch.

